Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicine, announced today the publication of foundational research demonstrating the power of its proprietary ...

Information sessions are scheduled for Wednesday about Lincoln Land Community College-Jacksonville's program to help ...

Microrobots navigating bloodstream to reach and treat clots show 95 % success in lab tests, potentially transforming stroke ...

NPM1 mutations, one of the most common genetic drivers of AML, are now actionable for patients –– Acute unmet need in R/R ...

The National Transportation Safety Board has released its preliminary report on the October plane crash in Bath Township that ...

A Fort Lauderdale city commissioner and the dean of Nova Southeastern University’s Guy Harvey Oceanographic Research Center ...

Despite challenges like high treatment costs, especially in developing regions, and underdiagnosis, the CAD market is expanding with the integration of digital health and precision medicine, promising ...

Medley Therapeutics, Inc. (formerly YAP Therapeutics), a company developing regenerative genetic medicines and advanced biologics, today announced completion of dosing in the first cohort (n=3) of the ...

CAMBRIDGE, Mass., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has completed the acquisition of Alcyone Therapeutics, a clinical-stage biotechnology company known for its innovative ...

As the automotive world races towards connected, electric and software-defined vehicles, cybersecurity has emerged not just ...

Panelists discuss how emerging therapies like menin inhibitors show promise based on strong preclinical data and clinical responses, while CD47 inhibitors have faced setbacks in phase 3 trials, with ...

Below you'll find MLA Tim McLeod and MLA Megan Patterson's Report from the Legislature for November 12, 2025. The views expressed below are solely the opinions of the authors and do not necessarily ...